image
Financial Services - Asset Management - NASDAQ - US
$ 134.12
-1.14 %
$ 7.65 B
Market Cap
24.79
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HLNE stock under the worst case scenario is HIDDEN Compared to the current market price of 134 USD, Hamilton Lane Incorporated is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HLNE stock under the base case scenario is HIDDEN Compared to the current market price of 134 USD, Hamilton Lane Incorporated is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HLNE stock under the best case scenario is HIDDEN Compared to the current market price of 134 USD, Hamilton Lane Incorporated is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart HLNE

image
$210.0$210.0$200.0$200.0$190.0$190.0$180.0$180.0$170.0$170.0$160.0$160.0$150.0$150.0$140.0$140.0$130.0$130.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
554 M REVENUE
4.74%
249 M OPERATING INCOME
-0.91%
227 M NET INCOME
21.38%
121 M OPERATING CASH FLOW
-46.66%
-122 M INVESTING CASH FLOW
-68.68%
4.4 M FINANCING CASH FLOW
101.21%
168 M REVENUE
12.17%
75.8 M OPERATING INCOME
15.24%
77.5 M NET INCOME
-25.56%
64.4 M OPERATING CASH FLOW
-40.47%
-42.9 M INVESTING CASH FLOW
-91.25%
73 M FINANCING CASH FLOW
109.07%
Balance Sheet Hamilton Lane Incorporated
image
Current Assets 257 M
Cash & Short-Term Investments 115 M
Receivables 127 M
Other Current Assets 16.1 M
Non-Current Assets 1.01 B
Long-Term Investments 632 M
PP&E 95.4 M
Other Non-Current Assets 286 M
9.02 %9.96 %49.74 %7.51 %22.51 %Total Assets$1.3b
Current Liabilities 247 M
Accounts Payable 4.5 M
Short-Term Debt 0
Other Current Liabilities 243 M
Non-Current Liabilities 504 M
Long-Term Debt 275 M
Other Non-Current Liabilities 229 M
32.30 %36.60 %30.50 %Total Liabilities$751.9m
EFFICIENCY
Earnings Waterfall Hamilton Lane Incorporated
image
Revenue 554 M
Cost Of Revenue 201 M
Gross Profit 352 M
Operating Expenses 103 M
Operating Income 249 M
Other Expenses 21.7 M
Net Income 227 M
600m600m500m500m400m400m300m300m200m200m100m100m00554m(201m)352m(103m)249m(22m)227mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
63.62% GROSS MARGIN
63.62%
44.95% OPERATING MARGIN
44.95%
25.43% NET MARGIN
25.43%
26.82% ROE
26.82%
11.08% ROA
11.08%
19.61% ROIC
19.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Hamilton Lane Incorporated
image
250m250m200m200m150m150m100m100m50m50m00201620162017201720182018201920192020202020212021202220222023202320242024
Net Income 227 M
Depreciation & Amortization 8.19 M
Capital Expenditures -11.1 M
Stock-Based Compensation 12.1 M
Change in Working Capital -42.4 M
Others -143 M
Free Cash Flow 110 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Hamilton Lane Incorporated
image
Wall Street analysts predict an average 1-year price target for HLNE of $118 , with forecasts ranging from a low of $78 to a high of $147 .
HLNE Lowest Price Target Wall Street Target
78 USD -41.84%
HLNE Average Price Target Wall Street Target
118 USD -11.83%
HLNE Highest Price Target Wall Street Target
147 USD 9.60%
Price
Max Price Target
Min Price Target
Average Price Target
22022020020018018016016014014012012010010080806060May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.42% DIVIDEND YIELD
0.49 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
2.00002.00001.80001.80001.60001.60001.40001.40001.20001.20001.00001.00000.80000.80000.60000.60000.40000.40000.20000.20000.00000.00000.1750.21250.2750.31250.350.40.4450.490.1750.21250.2750.31250.350.40.4450.490.1750.21250.2750.31250.350.40.4450.490.1750.700.21250.850.2751.100.31251.250.351.400.41.600.4451.780.491.960.00201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 3 of 2
6. Ownership
Insider Ownership Hamilton Lane Incorporated
image
Sold
0-3 MONTHS
1.63 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
106 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Hamilton Lane Partners with Dalan Real Estate to Acquire $74 million NYC Multifamily Portfolio CONSHOHOCKEN, Pa. , March 25, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, announced an investment in a portfolio of four multifamily assets in lower Manhattan. prnewswire.com - 3 weeks ago
Hamilton Lane Pioneers Access to Private Markets with the First U.S. Infrastructure Evergreen Fund Available to Retail Investors on Republic with a Minimum Initial Investment of $500 Hamilton Lane Private Infrastructure Fund ("HLPIF") allows retail investors access to infrastructure assets previously accessible only to Hamilton Lane's institutional clients Intention to offer investors access to HLPIF in a first-of-its-kind tokenized format through Republic's digital platform CONSHOHOCKEN, Pa. and NEW YORK , March 19, 2025  /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), one of the world's largest private markets investment firms, today announced the launch of HLPIF on the global investment platform Republic*. prnewswire.com - 1 month ago
2025 Hamilton Lane Market Overview: Private Markets Reach an Inflection Point, though Long-Term Fundamentals Remain Strong Research findings note some areas of concern in private markets in the short-term, with positive tailwinds across long-term fundamentals Report also highlights strong runway for growth within evergreen CONSHOHOCKEN, Pa. , March 12, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, published its 2025 Market Overview today. prnewswire.com - 1 month ago
Hamilton Lane Launches Private Secondary Fund in the U.S., Further Expanding Global Evergreen Platform Fund leverages firm's 24+ years of experience in the secondary market and extensive scale to capitalize on what the firm believes to be attractive long-term growth trends CONSHOHOCKEN, Pa. , March 3, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Private Secondary Fund ("HLPSF" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Company Act of 1940 ("40 Act"), available to U.S. accredited investor clients, including sufficiently qualified high-net-worth investors and their wealth advisors. prnewswire.com - 1 month ago
Hamilton Lane co-CEO Erik Hirsch on what is gumming up the IPO pipeline right now Erik Hirsch, Hamilton Lane Co-CEO, joins 'Closing Bell Overtime' to talk why the IPO boom isn't materializing. youtube.com - 1 month ago
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recomm. businesswire.com - 1 month ago
Hamilton Lane Q3 Earnings: Slowing Momentum, But Shares Remain Expensive Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was muted, up just 6% year over year. While growth is expected to slowdown in the coming quarters, shares remain richly valued at 34.6 times earnings. seekingalpha.com - 2 months ago
Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 1,572,536 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $252 million. prnewswire.com - 2 months ago
Market viewing tariffs as negotiating tactic right now, says Hamilton Lane's Hirsch Erik Hirsch, Hamilton Lane Co-CEO, joins 'Fast Money' to talk the impact of tariffs on the market. youtube.com - 2 months ago
Hamilton Lane Announces Public Offering of Class A Common Stock CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 1,572,536 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions. prnewswire.com - 2 months ago
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations. businesswire.com - 2 months ago
Hamilton Lane Closes Inaugural Venture Access Fund with Over $615 Million in Commitments, Exceeding Target Fund Size The Fund features a high-quality venture portfolio targeting top-performing, oversubscribed funds and companies CONSHOHOCKEN, Pa. , Feb. 6, 2025 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the final close of its Venture Access Fund ("VAF" or "the Fund"), which successfully exceeded its target fund size, raising $615.3 million in commitments. prnewswire.com - 2 months ago
8. Profile Summary

Hamilton Lane Incorporated HLNE

image
COUNTRY US
INDUSTRY Asset Management
MARKET CAP $ 7.65 B
Dividend Yield 0.42%
Description Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting services); and reporting and analytics solutions. For direct investments, the firm invests in early, mid and late venture, mature companies, growth equity, emerging growth, distressed debt, later stage, turnarounds, bridge financing, mezzanine financing, and buyouts in middle market companies. For fund of fund investments, it invests in mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situation funds. The firm invests in real estate investments. It also invest in technology, healthcare, education, natural resources, energy and essential consumer goods sectors, cleantech, and environment, community development, and financial empowerment. It invests in private equity markets in North America, Latin America, United States, Western Europe, Middle East, Africa, United Kingdom, Asia, Japan, and Australia. The firm prefer to invest $1 million to $100 million in companies. It prefers to have majority stake in companies. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, and Asia.
Contact 110 Washington Street, Conshohocken, PA, 19428 https://www.hamiltonlane.com
IPO Date March 1, 2017
Employees 700
Officers Mr. Jeffrey B. Armbrister Chief Financial Officer Mr. Hartley Raymond Rogers Executive Co-Chairman Mr. Drew T. Carl CPA MD & Chief Accounting Officer Mr. Erik R. Hirsch Co-Chief Executive Officer & Member of the Board Dr. Juan M. Delgado-Moreira C.F.A., Ph.D. Co-Chief Executive Officer & Member of the Board Mr. Andrew Schardt Vice Chairman, Head of Investment Strategy & Co-Head of Direct Equity Mr. Thomas J. Kerr Co-Head of Investments & Co-Head of Secondary Investments Ms. Andrea F. Kramer Chief Operating Officer & Chief Risk Officer Mr. Mario Lucio Giannini J.D. Executive Co-Chairman Ms. Lydia A. Gavalis J.D. General Counsel